品管圈在改善腹膜透析患者矿物质和骨代谢异常中的应用研究
Application of Quality Control Circle in Improving Mineral and Bone Disorder in Peritoneal Dialysis Patients
DOI: 10.12677/ACM.2022.1281081, PDF,    科研立项经费支持
作者: 李 静, 张宜明*, 李 相, 马小芬, 季媛媛, 骆纳纳:济宁医学院临床医学院,山东 济宁
关键词: 腹膜透析品管圈MBDPeritoneal Dialysis Quality Control Circle MBD
摘要: 目的:探讨品管圈(Quality Control Circle, QCC)在改善腹膜透析患者矿物质和骨代谢紊乱(mineral and bone disorder, MBD)中的作用。方法:将89例出院后需要进行腹膜透析的患者按随机抽样法分为QCC组(45例)和对照组(44例)。两组均实施常规的随访管理,QCC组在此基础上按照制定的QCC活动流程实施QCC活动,两组干预时间均为1年。比较两组血磷、血钙、全段甲状旁腺素(iPTH)、维生素D、碱性磷酸酶等指标。结果:QCC组与对照组相比,血磷[(1.64 ± 0.26) mmol/L比(1.83 ± 0.27) mmol/L, t = 3.549, P = 0.001]、iPTH [(289.55 ± 180.55) pg/ml比(416.51 ± 285.80) pg/ml, t = 2.499, P = 0.015]、ALP [(87.26 ± 59.79) U/L比(107.96 ± 72.26) U/L, t = 2.156, P = 0.031]较低,有统计学意义;QCC组与对照组相比,矫正后血钙[(2.30 ± 0.24)比(2.18 ± 0.30), t = 2.123, P = 0.036]、维生素D [(12.78 ± 5.16) IU比(9.74 ± 4.23) IU, t = 3.036, P = 0.003]较高;QCC组与对照组相比血清白蛋白、前白蛋白、MQSGA无统计学意义。Spearman相关性分析结果显示,血磷水平与受教育程度呈负相关(r = −0.29, P < 0.05),血清白蛋白水平与受教育程度呈正相关(r = 0.20, P < 0.05)。结论:QCC管理模式能改善腹膜透析患者的矿物质和骨代谢异常。
Abstract: Objective: To explore the effect of Quality Control Circle (QCC) in improving mineral and bone dis-order (MBD) in patients with peritoneal dialysis. Methods: 89 patients who required peritoneal di-alysis after discharge were randomly divided into QCC group (45 cases) and control group (44 cases). The two groups underwent routine follow-up management. On the basis of this, the QCC group im-plemented QCC activities according to the established QCC activity process. The intervention time was 1 year. Serum phosphorus, Serum calcium, iPTH, vitamin D and other indicators were com-pared between the two groups. Results: Compared with the control group, the serum phosphorus of QCC group (1.64 ± 0.26 mmol/L vs (1.83 ± 0.27) mmol/L, t = 3.549, P = 0.001), iPTH [(289.55 ± 180.55) pg/ml vs (416.51 ± 285.80) pg/ml, t = 2.499, P = 0.015], ALP [(87.26 ± 59.79) U/L vs (107.96 ± 72.26) U/L, t = 2.156, P = 0.031] is low, which has statistical significance; Corrected serum calcium [(2.30 ± 0.24) vs. (2.18 ± 0.30), t = 2.123, P = 0.036], vitamin D [(12.78 ± 5.16) IU vs. (9.74) ± 4.23] IU, t = 3.036, P = 0.003] were higher in QCC group than in control group; serum albumin, prealbumin, and MQSGA had no statistical differences between the two groups. Spearman correla-tion analysis showed that serum phosphorus levels were negatively correlated with education (r = −0.29, P < 0.05), and serum albumin levels were positively correlated with education (r = 0.20, P < 0.05). Conclusion: The QCC management model can improve mineral and bone disorder in perito-neal dialysis patients.
文章引用:李静, 张宜明, 李相, 马小芬, 季媛媛, 骆纳纳. 品管圈在改善腹膜透析患者矿物质和骨代谢异常中的应用研究[J]. 临床医学进展, 2022, 12(8): 7490-7495. https://doi.org/10.12677/ACM.2022.1281081

参考文献

[1] 吴繁香. 应用5W1H对脑出血患者进行早期康复护理[C]//中国康复护理学术高峰论坛暨推进优质护理服务研讨会. 中国康复护理学术高峰论坛暨推进优质护理服务研讨会论文集. 武汉: 中国康复医学会康复护理专业委员会, 2012: 161-163.
[2] Tilman, B.D. and Olgaard, K. (2013) Report on 2012 ISN Nexus Symposium: “Bone and the Kidney”. Kidney International, 83, 557-562. [Google Scholar] [CrossRef] [PubMed]
[3] Mark, G., Maria, C. and Sangeet, G. (2013) Continuous Ambulatory Peritoneal Dialysis—A Guide to Imaging Appearances and Complications. Insights into Imaging, 4, 85-92. [Google Scholar] [CrossRef] [PubMed]
[4] Kalantar-Zadeh, K. (2013) Patient Education for Phosphorus Management in Chronic Kidney Disease. Patient Preference and Adherence, 7, 379-390. [Google Scholar] [CrossRef
[5] Luxia, Z., Fang, W., Li, W., et al. (2012) Prevalence of Chronic Kidney Disease in China: A Cross-Sectional Survey. The Lancet, 380, 214-214. [Google Scholar] [CrossRef
[6] Muhammad Ziad, S. and Faissal Abdulraheem, S. (2010) Survey of Attitudes of Physicians toward the Current Evaluation and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Saudi Journal of Kidney Diseases and Transplantation, 21, 93-101.
[7] Tentori, F., Blayney, M.J., Albert, J.M., et al. (2008) Mortality Risk for Dialysis Patients with Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Dis-eases, 52, 519-530. [Google Scholar] [CrossRef] [PubMed]
[8] 张瑾, 许辉, 袁琼婧, 等. 维持透析时间对腹膜透析患者CKD-MBD的影响[J]. 国际泌尿系统杂志, 2014, 34(6): 896-900.
[9] Isakova, T., et al. (2017) KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Preven-tion, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). American Journal of Kidney Diseases, 70, 737-751. [Google Scholar] [CrossRef] [PubMed]
[10] Palmer, S.C., Andrew, H., Petra, M., et al. (2011) Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. JAMA: The Journal of the Amer-ican Medical Association, 305, 1119-1127. [Google Scholar] [CrossRef] [PubMed]
[11] Block, G.A. (2011) Therapeutic Interventions for Chronic Kidney Dis-ease-Mineral and Bone Disorders: Focus on Mortality. Current Opinion in Nephrology & Hypertension, 20, 376-376. [Google Scholar] [CrossRef
[12] 李相, 马小芬, 张宜明. 品管圈在降低腹膜透析患者并发症发生率中的应用研究[J]. 中国医师进修杂志, 2017, 40(7): 614-617.
[13] 王善志, 朱永俊, 李国铨, 钟良宝. 中国成人慢性肾脏病患病率的Meta分析结果及对比[J]. 中华肾脏病杂志, 2018, 34(8): 579-586.
[14] 张萌, 马倩文, 万艳平. 慢性肾脏病患者高磷血症的管理[J]. 当代医学, 2021, 27(31): 191-194.
[15] 林腾强, 毛石清, 叶晓艺. 维持性腹膜透析患者血25-羟维生素D水平及其相关因素分析[J]. 中国当代医药, 2020, 27(36): 77-79.
[16] Ferreira, A.C., et al. (2021) The Role of Bone Biopsy in the Management of CKD-MBD. Calcified Tissue International, 108, 528-538.
[17] 鲁晓涵, 郑艳丹, 林海霞, 吴小燕, 高苹. 维持性血液透析患者血清碱性磷酸酶和甲状旁腺激素水平与全因死亡及心血管事件死亡相关性[J]. 武汉大学学报(医学版), 2020, 41(2): 285-290.
[18] 付高宁, 张丽. 慢性肾脏病患者蛋白质能量消耗机制的研究进展[J]. 临床肾脏病杂志, 2021, 21(9): 776-779.
[19] 杨艳. 慢性肾脏病患者蛋白质-能量消耗与膳食摄入的关系及早期预警[D]: [硕士学位论文]. 兰州: 兰州大学, 2018.